Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Literature DB >> 21908499

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

F Cardoso¹, L Fallowfield, A Costa, M Castiglione, E Senkus.

Abstract

Entities: Disease

Mesh：

Year: 2011 PMID： 21908499 DOI： 10.1093/annonc/mdr372

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

37 in total

1. Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians.

Authors: Raffaella Palumbo; Federico Sottotetti; Alberto Riccardi; Cristina Teragni; Emma Pozzi; Erica Quaquarini; Barbara Tagliaferri; Antonio Bernardo
Journal: Ther Adv Med Oncol Date: 2013-11 Impact factor: 8.168

Review 2. Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Authors: Dae Y Kim; Jose A Karam; Christopher G Wood
Journal: World J Urol Date: 2014-04-18 Impact factor: 4.226

Review 3. Luminal breast cancer: from biology to treatment.

Authors: Michail Ignatiadis; Christos Sotiriou
Journal: Nat Rev Clin Oncol Date: 2013-07-23 Impact factor: 66.675

4. Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer.

Authors: Marco daCosta DiBonaventura; Ronda Copher; Enrique Basurto; Claudio Faria; Rose Lorenzo
Journal: Am Health Drug Benefits Date: 2014-10

Review 5. Progress in circulating tumor cell capture and analysis: implications for cancer management.

Authors: Marija Balic; Henry Lin; Anthony Williams; Ram H Datar; Richard J Cote
Journal: Expert Rev Mol Diagn Date: 2012-04 Impact factor: 5.225

6. Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers.

Authors: Ji-Hyun Lee; Xing-Ming Zhao; Ina Yoon; Jin Young Lee; Nam Hoon Kwon; Yin-Ying Wang; Kyung-Min Lee; Min-Joo Lee; Jisun Kim; Hyeong-Gon Moon; Yongho In; Jin-Kao Hao; Kyung-Mii Park; Dong-Young Noh; Wonshik Han; Sunghoon Kim
Journal: Cell Discov Date: 2016-08-30 Impact factor: 10.849

7. Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective.

Authors: Marcio Machado; Thomas R Einarson
Journal: Breast Cancer (Dove Med Press) Date: 2012-11-13